<?xml version="1.0" encoding="UTF-8"?>
<ref id="B118-viruses-12-00518">
 <label>118.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Mugabe</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Borisov</surname>
    <given-names>O.V.</given-names>
   </name>
  </person-group>
  <article-title>Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates</article-title>
  <source>Anal. Biochem.</source>
  <year>2020</year>
  <volume>592</volume>
  <fpage>113577</fpage>
  <pub-id pub-id-type="doi">10.1016/j.ab.2020.113577</pub-id>
  <pub-id pub-id-type="pmid">31926146</pub-id>
 </element-citation>
</ref>
